JP Morgan Chase’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,900
Closed -$1.04M 7490
2025
Q4
$1.04M Hold
12,900
﹤0.01% 4584
2025
Q3
$1.26M Buy
+12,900
New +$1.04M ﹤0.01% 4419

Other funds holding ACLS

JP Morgan Chase's ACLS Position: Q2 2026 in Review

JP Morgan Chase reduced its Axcelis (ACLS) stake by 80% in Q2 2026, selling an estimated $26.5M and leaving 44,011 shares worth $8M. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

JP Morgan Chase first reported a position in ACLS in Q2 2013 and has held it in 46 quarters since. The position peaked at $73.2M in Q4 2023. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • JP Morgan Chase held 44,011 shares of Axcelis worth $8M as of Q2 2026.
  • JP Morgan Chase sold 178,703 Axcelis shares in Q2 2026, an estimated $26.5M.
  • Axcelis made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3019 holding.
  • JP Morgan Chase first reported a position in Axcelis in Q2 2013 and has held it in 46 quarters since.
  • JP Morgan Chase's Axcelis position peaked at $73.2M in Q4 2023.
  • 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.